GE HealthCare Technologies (GEHC) – Analysts’ Recent Ratings Changes

Several analysts have recently updated their ratings and price targets for GE HealthCare Technologies (NASDAQ: GEHC):

• 7/31/2026 – GE HealthCare Technologies had its price target raised by UBS Group AG from $67.00 to $73.00. They now have a “neutral” rating on the stock.
• 7/30/2026 – GE HealthCare Technologies had its “outperform” rating reaffirmed by Evercore Inc. They now have a $84.00 price target on the stock.
• 7/30/2026 – GE HealthCare Technologies had its “outperform” rating reaffirmed by Oppenheimer Holdings, Inc..
• 7/30/2026 – GE HealthCare Technologies had its price target raised by Citigroup Inc. from $69.00 to $75.00. They now have a “neutral” rating on the stock.
• 7/30/2026 – GE HealthCare Technologies had its price target raised by Wells Fargo & Company from $75.00 to $85.00. They now have an “overweight” rating on the stock.
• 7/29/2026 – GE HealthCare Technologies had its “buy” rating reaffirmed by Piper Sandler.
• 7/29/2026 – GE HealthCare Technologies had its price target raised by BTIG Research from $75.00 to $79.00. They now have a “buy” rating on the stock.
• 7/21/2026 – GE HealthCare Technologies was downgraded by Zacks Research from “hold” to “strong sell”.
• 7/17/2026 – GE HealthCare Technologies is now covered by Hovde Group. They set a “market perform” rating and a $14.00 price target on the stock.
• 7/16/2026 – GE HealthCare Technologies had its price target lowered by UBS Group AG from $69.00 to $67.00. They now have a “neutral” rating on the stock.
• 7/13/2026 – GE HealthCare Technologies had its “buy” rating reaffirmed by BTIG Research. They now have a $75.00 price target on the stock.
• 7/8/2026 – GE HealthCare Technologies is now covered by BMO Capital Markets. They set a “market perform” rating and a $70.00 price target on the stock.
• 7/8/2026 – GE HealthCare Technologies had its “neutral” rating reaffirmed by Citigroup Inc..
• 7/8/2026 – GE HealthCare Technologies was upgraded by BMO Capital Markets to “hold”.
• 6/23/2026 – GE HealthCare Technologies is now covered by Royal Bank Of Canada. They set an “outperform” rating and a $80.00 price target on the stock.
• 6/23/2026 – GE HealthCare Technologies is now covered by Royal Bank Of Canada. They set an “outperform” rating and a $80.00 price target on the stock.
• 6/8/2026 – GE HealthCare Technologies had its “neutral” rating reaffirmed by The Goldman Sachs Group, Inc..

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.21%.

Insider Transactions at GE HealthCare Technologies

In other news, Director Watkin Phoebe L. Yang bought 1,000 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 8th. The shares were acquired at an average price of $63.01 per share, with a total value of $63,010.00. Following the completion of the purchase, the director owned 13,702 shares in the company, valued at $863,363.02. The trade was a 7.87% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Rodney F. Hochman acquired 1,618 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was purchased at an average cost of $62.03 per share, with a total value of $100,364.54. Following the purchase, the director owned 1,618 shares of the company’s stock, valued at $100,364.54. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders purchased 12,618 shares of company stock worth $805,175. 0.36% of the stock is currently owned by company insiders.

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.